BOSTON (MarketWatch) -- While pharmaceutical and biotech stocks weakened Friday, shares of GPC Biotech AG and Spectrum Pharmaceuticals plunged after documents were posted on the Food and Drug ...
The pharmaceutical regroups, awaiting more data on a crucial drug candidate. GPC Biotech (NASDAQ:GPCB) announced its second-quarter financial results earlier in the week, in the shadow of a setback ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Germany's GPC Biotech AG, which operates a facility in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results